CRWM
DXCM icon

Castle Rock Wealth Management’s DexCom DXCM Stock Holding History

Castle Rock Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,360
Closed -$536K – 221
2022
Q1 		$536K Sell
4,360
-4,352
-50% -$476K 0.25% 123
2021
Q4 		$919K Sell
8,712
-2,996
-26% -$431K 0.37% 73
2021
Q3 		$1.86M Buy
11,708
+156
+1% +$19.7K 0.64% 46
2021
Q2 		$1.44M Buy
11,552
+408
+4% +$39.2K 0.53% 59
2021
Q1 		$1.14M Buy
11,144
+1,064
+11% +$99.9K 0.46% 72
2020
Q4 		$933K Buy
10,080
+1,592
+19% +$142K 0.39% 84
2020
Q3 		$823K Buy
8,488
+1,656
+24% +$173K 0.54% 63
2020
Q2 		$755K Buy
6,832
+3,480
+104% +$311K 0.44% 71
2020
Q1 		$338K Buy
+3,352
New +$209K 0.29% 88

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Castle Rock Wealth Management's DXCM Position: Q2 2022 in Review

Castle Rock Wealth Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 4,360 shares — an estimated $536K sold.

Castle Rock Wealth Management first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $1.86M in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Castle Rock Wealth Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Castle Rock Wealth Management sold 4,360 DexCom shares in Q2 2022, an estimated $536K.
  • Castle Rock Wealth Management first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • Castle Rock Wealth Management's DexCom position peaked at $1.86M in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Castle Rock Wealth Management's 13F filing for Q2 2022, filed 13 Jul 2022.